Skip to main content

Peer Review reports

From: Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1

Original Submission
3 Oct 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
19 Mar 2015 Editorially accepted
3 Apr 2015 Article published 10.1186/s12885-015-1229-6

You can find further information about peer review here.

Back to article page